DVAX |
DYNAVAX TECHNOLOGIES CORP |
May 23, 2024 |
2 |
$0 |
4 |
May 28, 2024 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Mar 11, 2024 |
3 |
$0 |
4 |
Mar 11, 2024 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Jan 1, 2024 |
1 |
$0 |
4 |
Jan 3, 2024 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Nov 27, 2023 |
1 |
$0 |
4 |
Nov 28, 2023 |
Director |
SELB |
Cartesian Therapeutics, Inc. |
Nov 13, 2023 |
5 |
-$81.4K |
4 |
Nov 15, 2023 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Oct 1, 2023 |
1 |
$0 |
4 |
Oct 2, 2023 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Jul 1, 2023 |
1 |
$0 |
4 |
Jul 6, 2023 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Jun 22, 2023 |
1 |
$0 |
4 |
Jun 23, 2023 |
Director |
DVAX |
DYNAVAX TECHNOLOGIES CORP |
May 26, 2023 |
2 |
$0 |
4 |
May 31, 2023 |
Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Apr 12, 2023 |
1 |
$101K |
4 |
Apr 12, 2023 |
Chief Executive Officer, Director |
HARP |
Harpoon Therapeutics, Inc. |
Apr 1, 2023 |
1 |
$0 |
4 |
Apr 4, 2023 |
Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Mar 13, 2023 |
1 |
$160K |
4 |
Mar 13, 2023 |
Chief Executive Officer, Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Feb 6, 2023 |
2 |
$0 |
4 |
Feb 7, 2023 |
Chief Executive Officer, Director |
VRDN |
Viridian Therapeutics, Inc.\DE |
Feb 6, 2023 |
0 |
$0 |
3 |
Feb 7, 2023 |
Chief Executive Officer, Director |
SELB |
SELECTA BIOSCIENCES INC |
Jan 2, 2023 |
1 |
$0 |
4 |
Jan 4, 2023 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Jun 22, 2022 |
1 |
$0 |
4 |
Jun 24, 2022 |
Director |
DVAX |
DYNAVAX TECHNOLOGIES CORP |
May 26, 2022 |
2 |
$0 |
4 |
May 27, 2022 |
Director |
SELB |
SELECTA BIOSCIENCES INC |
Jan 3, 2022 |
1 |
$0 |
4 |
Jan 5, 2022 |
Director |
TRIL |
Trillium Therapeutics Inc. |
Nov 17, 2021 |
1 |
$0 |
4 |
Nov 19, 2021 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Oct 25, 2021 |
1 |
$0 |
4 |
Oct 26, 2021 |
Director |
DVAX |
DYNAVAX TECHNOLOGIES CORP |
Oct 19, 2021 |
2 |
$0 |
4 |
Oct 21, 2021 |
Director |
DVAX |
DYNAVAX TECHNOLOGIES CORP |
Oct 19, 2021 |
0 |
$0 |
3 |
Oct 21, 2021 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
May 4, 2021 |
1 |
$0 |
4/A |
May 14, 2021 |
Director |